The Mina & Everard Goodman Faculty of Life Sciences and the Institute for Nanotechnology and Advanced Materials, Bar Ilan University, Ramat Gan, Israel.
Commun Biol. 2022 Oct 28;5(1):1147. doi: 10.1038/s42003-022-04103-3.
Protein degradation mediated by the ubiquitin-proteasome pathway regulates signaling events in many physiological and pathological conditions. In vitro degradation assays have been instrumental in the understanding of how cell proliferation and other fundamental cellular processes are regulated. These assays are direct, time-specific and highly informative but also laborious, typically relying on low-throughput polyacrylamide gel-electrophoresis followed by autoradiography or immunoblotting. We present protein degradation on chip (pDOC), a MITOMI-based integrated microfluidic technology for discovery and analysis of proteins degradation in cell-free extracts. The platform accommodates hundreds of microchambers on which protein degradation is assayed quickly, simultaneously and using minute amounts of reagents in one or many physiochemical environments. Essentially, pDOC provides a sensitive multiplex alternative to the conventional degradation assay, with relevance to biomedical and translational research associated with regulated proteolysis.
蛋白降解通过泛素-蛋白酶体途径调节许多生理和病理条件下的信号事件。体外降解测定法在理解细胞增殖和其他基本细胞过程如何被调节方面发挥了重要作用。这些测定法是直接的、特定时间的、信息量丰富的,但也很繁琐,通常依赖于低通量的聚丙烯酰胺凝胶电泳,然后进行放射自显影或免疫印迹。我们提出了芯片上的蛋白降解(pDOC),这是一种基于 MITOMI 的集成微流控技术,用于在无细胞提取物中发现和分析蛋白降解。该平台可容纳数百个微室,可快速、同时并使用少量试剂在一个或多个物理化学环境中进行蛋白降解测定。从本质上讲,pDOC 提供了一种对传统降解测定法的灵敏多重替代方法,与与调节蛋白水解相关的生物医学和转化研究相关。